摘要:
The present invention aims to provide a novel method for producing an aqueous dispersion containing non-melt-processable polytetrafluoroethylene particles. The present invention relates to a method for producing an aqueous dispersion containing non-melt-processable polytetrafluoroethylene particles, the method including polymerizing tetrafluoroethylene in an aqueous medium in the presence of perfluoro hexanoic acid or its salt.
摘要:
Methods, apparatuses, and computer program products for memory access to a dual in-line memory module (DIMM) form factor flash memory are provided. Embodiments include receiving, by a controller from a processor through cacheable memory in the processor, a read request; transmitting, by the controller, the read request to the DIMM form factor flash memory; polling, by the controller, a read queue in the DIMM form factor flash memory until data is ready for the read request; copying from the DIMM form factor flash memory, by the controller, the data corresponding to the read request to a read queue in the controller; transmitting, by the controller on an interface between the controller and the processor, an invalidate command for the cacheable memory; and in response to receiving the invalidate command, reading by the processor the data stored in the read queue in the controller.
摘要:
Disclosed are a device, a system, and a method for setting standard work times that take real-world manufacturing capabilities into account. Provided is a standard work time calculation device (10), which analyzes fluctuations in production line assessment indices on a per time period basis, and computes standard work times for each region, as classified according to the degree of fluctuation. The standard work time calculation device (10) comprises a fluctuation coefficient computation unit (111), which computes coefficients of fluctuation for the assessment indices, a fluctuation region identification unit (112), which identifies regions of fluctuation with coefficients of fluctuation that are greater than or equal to predetermined thresholds, and a standard work time computation unit (113), which computes standard work times for regions of fluctuation.
摘要:
A compound represented by the general formula (1): -Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4 (1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof.The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
摘要:
A navigation device realizes such processing as map display and route guidance based on map data stored in a memory card. The data in the memory card tends to be volatilized with an increase in the frequency of reading of data. Therefore, the data that are highly frequently read out are held in a RAM so as to be read from the memory card at a decreased frequency. Further, the passage of time is calculated from the date and hour the data are recorded in the memory card, and the whole data in the memory card are refreshed every time when the passage of time exceeds a threshold value T1.
摘要:
The present invention relates to diamine compounds which inhibit activated blood coagulation factor X and exhibit an anticoagulant effect and there uses for treating various diseases based on thromboembolism.
摘要:
A method for controlling the different power states of a ClientBlade™ from a remote desktop environment is described. A remote user is permitted to control the different power states of the ClientBlade™ remotely via a remote client having an operating system or a thin client (or decompression brick) with no operating system. Administered authentication of the remote user is required before access is granted to the management module in the BladeCenter™ environment to enable the changes to the power state of the ClientBlade™.
摘要:
A method for controlling the different power states of a ClientBlade™ from a remote desktop environment is described. The remote user's (device) connects his computer device (laptop or desktop) to the ClientBlade™ (at the Blade Center) via a Remote Desktop Protocol (RDP), which performs minimal video compression and provides an Ethernet connection back to the Blade Center. The user inputs a pre-defined key sequence, which initiates a power state interface (or input screen). The power state interface allows the user to select one of several power states. Once the power state is selected, a TCP/IP packet is generated and transmitted from the computer device to the ClientBlade™. The packet invokes the selected power state at the ClientBlade™. Once the power state is activated, a completion message verifying the power state change is sent back to the end user's computer device.
摘要:
The invention provides a TFE polymer capable of providing stretched materials excellent in membrane homogeneity. The present invention is related to a tetrafluoroethylene polymer having stretchability and non-melt-processability and having a standard specific gravity of 2.140 to 2.165, wherein, with regard to the heat-of-fusion curve obtained by subjecting the tetrafluoroethylene polymer in the form of an unbaked polymer to be measured having no history of being heated to a temperature of 300° C. or higher to differential scanning calorimetry at a programming rate of 2° C./minute, the ratio S2/S1 is not lower than 0.90.
摘要:
A method for treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing is provided. The method includes administration of an effective amount of a compound represented by formula (1):